• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    INNOVATE Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    6/20/24 4:13:13 PM ET
    $VATE
    Metal Fabrications
    Industrials
    Get the next $VATE alert in real time by email
    hchc-20240618
    false000100683712/31TRUE00010068372024-06-182024-06-180001006837hchc:CommonStockParValue0001PerShareMember2024-06-182024-06-180001006837hchc:PreferredStockPurchaseRightsMember2024-06-182024-06-18

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of Earliest Event Reported):June 18, 2024

    INNOVATE CORP.
    (Exact name of registrant as specified in its charter)
    Delaware001-3521054-1708481
    (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
    295 Madison Ave, 12th Fl
     
    New York, NY
     
    10017
    (Address of principal executive offices) (Zip Code)
    Registrant’s telephone number, including area code: 
    (212) 235-2691
    Former name or former address, if changed since last report

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    Common Stock, par value $0.001 per shareVATENew York Stock Exchange
    Preferred Stock Purchase Rights
    N/ANew York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





    Item 3.02Unregistered Sales of Equity Securities

    In connection with the Company's previously disclosed rights offering, the Company sold approximately 31.3 thousand shares of Series C Non-Voting Convertible Participating Preferred Stock, par value $0.001 per share (the “Preferred Stock”) to Lancer Capital LLC (“Lancer Capital”). Pursuant to the previously filed Certificate of Designations of the Preferred Stock, the Preferred Stock automatically converted to 44,693,895 shares of Common Stock, par value $0.001 per share, upon the approval of such conversion by the stockholders at the Annual Meeting. This issuance and sale was consummated without registration under the Securities Act, in reliance upon an exemption from the registration requirements of the Securities Act under Section 3(a)(9) of the Securities Act.

    Item 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

    On June 18, 2024, INNOVATE Corp. (the “Company”) amended its Second Amended and Restated Certificate of Incorporation (as previously amended, the “Certificate of Incorporation”) to provide for exculpation of certain officers of the Company as permitted by recent amendments to Delaware law and to increase the number of authorized shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), from 160,000,000 to 250,000,000 shares.

    The foregoing description of the amendments to the Certificate of Incorporation does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment of Certificate of Incorporation filed with the Secretary of State of Delaware on June 18, 2024, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

    Item 5.07Submission of Matters to a Vote of Security Holders

    The Annual Meeting of Stockholders (the “Annual Meeting”) of the Company was held on June 18, 2024. The final voting results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:

    Proposal 1:Election of Directors

    The stockholders voted to elect the following four nominees as members of the Board of Directors of the Company, each to hold office until the Company’s 2025 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified. The results of the vote were as follows:

    Director NameForAgainstAbstainBroker Non-Votes
    Avram A. Glazer56,081,4122,133,3362,669,57912,340,830
    Warren H. Gfeller57,244,535908,3882,731,40412,340,830
    Brian S. Goldstein57,162,965935,0582,786,30412,340,830
    Amy M. Wilkinson57,380,247718,3032,785,77712,340,830




    Proposal 2:Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers (“Say on Pay Vote”)

    The stockholders voted to approve the non-binding, advisory proposal on the compensation of the Company’s named executive officers. The results of the vote were as follows:

    ForAgainstAbstainBroker Non-Votes
    55,982,8511,817,6943,083,78212,340,830

    Proposal 3:
    Approval of Amendment to the Company’s Second Amended and Restated Certificate of Incorporation, as amended, to provide for exculpation of certain officers of the Company as permitted by recent amendments to Delaware law

    The stockholders voted to approve the amendment to the Certificate of Incorporation to provide for exculpation of certain officers of the Company as permitted by recent amendments to Delaware law. The results of the vote were as follows:

    ForAgainstAbstainBroker Non-Votes
    56,017,0524,297,571569,70412,340,830

    Proposal 4:
    Approval of Amendment to Company’s Second Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company’s common stock, par value $0.001

    The stockholders voted to approve the amendment to the Company’s Second Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company’s common stock, par value $0.001. The results of the vote were as follows:

    Common Stock, voting separately:

    ForAgainstAbstainBroker Non-Votes
    58,329,8349,613,140536,8330

    Common Stock and Preferred Stock, voting together as a single class:

    ForAgainstAbstainBroker Non-Votes
    63,075,1849,613,140536,8330




    Proposal 5:
    Approval of Amendment to Company’s Second Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our outstanding shares of Common Stock

    The stockholders voted to approve the amendment to the Company’s Second Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our outstanding shares of Common Stock. The results of the vote were as follows:

    ForAgainstAbstainBroker Non-Votes
    69,492,4093,616,259116,4890

    Proposal 6:
    Approval of Amendment to Second Amended and Restated 2014 Omnibus Equity Award Plan to increase the number of shares of Common Stock available for issuance thereunder

    The stockholders voted to approve the amendment to the Second Amended and Restated 2014 Omnibus Equity Award Plan to increase the number of shares of Common Stock available for issuance thereunder. The results of the vote were as follows:

    ForAgainstAbstainBroker Non-Votes
    59,386,2381,186,960311,12912,340,830

    Proposal 7:
    Approval of vesting on July 25, 2024, the first anniversary of the date on which his employment with the Company began, of restricted stock unit and stock option awards granted to our Interim Chief Executive Officer

    The stockholders voted to approve the vesting on July 25, 2024, the first anniversary of the date on which his employment with the Company began, of restricted stock unit and stock option awards granted to our Interim Chief Executive Officer. The results of the vote were as follows:

    ForAgainstAbstainBroker Non-Votes
    58,947,7001,072,039864,58812,340,830

    Proposal 8:
    Approval of conversion of 31,285.7265 shares of the Series C Preferred Stock into Common Stock in connection with the Rights Offering

    The stockholders voted to approve the conversion of 31,285.7265 shares of the Series C Preferred Stock into Common Stock in connection with the Rights Offering. The results of the vote were as follows:




    ForAgainstAbstainBroker Non-Votes
    58,981,1601,863,95439,21312,340,830

    Proposal 9:
    Ratification of the appointment of BDO USA, P.C., as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

    The stockholders voted to ratify the appointment of BDO USA, P.C., as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The results of the vote were as follows:

    ForAgainstAbstainBroker Non-Votes
    70,756,1172,351,000118,0400

    Item 9.01Financial Statements and Exhibits.

    (d)    Exhibits

    Exhibit No.  
     Description
    3.1
    Certificate of Amendment to Second Amended and Restated Certificate of Incorporation of INNOVATE Corp., as amended, dated June 18, 2024
    104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date: June 20, 2024
    INNOVATE Corp. (Registrant)
    By:/s/ Michael J. Sena
    Name: Michael J. Sena
    Title: Chief Financial Officer

    Get the next $VATE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VATE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VATE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Sena Michael J. covered exercise/tax liability with 7,911 shares, decreasing direct ownership by 6% to 115,982 units (SEC Form 4)

    4 - INNOVATE Corp. (0001006837) (Issuer)

    3/16/26 5:10:46 PM ET
    $VATE
    Metal Fabrications
    Industrials

    Amendment: SEC Form 4 filed by Director Glazer Avram A

    4/A - INNOVATE Corp. (0001006837) (Issuer)

    9/18/25 4:23:23 PM ET
    $VATE
    Metal Fabrications
    Industrials

    SEC Form 4 filed by Interim CEO Voigt Paul

    4 - INNOVATE Corp. (0001006837) (Issuer)

    9/17/25 4:37:51 PM ET
    $VATE
    Metal Fabrications
    Industrials

    $VATE
    SEC Filings

    View All

    SEC Form 10-K filed by INNOVATE Corp.

    10-K - INNOVATE Corp. (0001006837) (Filer)

    3/26/26 4:27:43 PM ET
    $VATE
    Metal Fabrications
    Industrials

    INNOVATE Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - INNOVATE Corp. (0001006837) (Filer)

    3/26/26 4:17:09 PM ET
    $VATE
    Metal Fabrications
    Industrials

    INNOVATE Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - INNOVATE Corp. (0001006837) (Filer)

    2/10/26 4:08:31 PM ET
    $VATE
    Metal Fabrications
    Industrials

    $VATE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $VATE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Interim CEO Voigt Paul bought $99,500 worth of shares (25,000 units at $3.98) (SEC Form 4)

    4 - INNOVATE Corp. (0001006837) (Issuer)

    11/21/24 4:49:08 PM ET
    $VATE
    Metal Fabrications
    Industrials

    Interim CEO Voigt Paul bought $166,383 worth of shares (43,785 units at $3.80), increasing direct ownership by 26% to 211,655 units (SEC Form 4)

    4 - INNOVATE Corp. (0001006837) (Issuer)

    9/16/24 4:17:05 PM ET
    $VATE
    Metal Fabrications
    Industrials

    Interim CEO Voigt Paul bought $106 worth of shares (176 units at $0.60), increasing direct ownership by 0.01% to 1,678,695 units (SEC Form 4)

    4 - INNOVATE Corp. (0001006837) (Issuer)

    6/17/24 4:36:10 PM ET
    $VATE
    Metal Fabrications
    Industrials

    INNOVATE Corp. Announces Fourth Quarter and Full Year 2025 Results

    - Infrastructure: NYC and Western markets continue to demonstrate positive project momentum -- Life Sciences: R2 Secures 600‑System Commitment in China -- Spectrum: Recent network launches set to deliver benefits beginning in 2026 - NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the fourth quarter and full year ended December 31, 2025. Financial Summary (in millions, except per share amounts)Three Months Ended December 31, Year Ended December 31,  2025   2024  Increase / (Decrease)  2025   2024  Increase / (Decrease)Revenue$382.7  $236.6  61.7% $1,246.0  $1,107.1  12.5%Net loss attributab

    3/26/26 4:05:00 PM ET
    $VATE
    Metal Fabrications
    Industrials

    INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th

    NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the fourth quarter and full year 2025 on Thursday, March 26, 2026, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please

    3/16/26 4:05:00 PM ET
    $VATE
    Metal Fabrications
    Industrials

    Transdermal GFR Article Recognized as One of Five 2025 Editors' Choice Articles by Journal of the American Society of Nephrology (JASN)

    MediBeacon® Transdermal GFR System is a first-in-kind product for point of care kidney function assessmentCenters of Excellence commercialization in select academic medical centers began in January 2026 NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that MediBeacon Inc. ("MediBeacon"), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, in which INNOVATE owns a 44.7% equity interest, announced that the peer-reviewed transdermal GFR measurement article published in the Journal of the American Society of Nephrology (JASN) has been recognized as one of

    2/10/26 4:05:00 PM ET
    $VATE
    Metal Fabrications
    Industrials

    $VATE
    Leadership Updates

    Live Leadership Updates

    View All

    MediBeacon Inc. Appoints Dr. Steve Miller as Chief Medical Officer

    MediBeacon expands management team as enrollment in Phase 3 study focused on kidney disease is completed ST. LOUIS, May 16, 2023 /PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE:VATE), today announced the appointment of Dr. Steve Miller as chief medical officer. In this role, Dr. Miller will be focused on driving a range of clinical and strategic initiatives. Dr. Miller formerly served as executive vice president and chief clinical officer at Cigna, where he led the company's clinical policy, quality, and per

    5/16/23 7:00:00 AM ET
    $VATE
    Metal Fabrications
    Industrials

    Catalent Appoints Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary

    Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary. Mr. Ferraro will be responsible for managing Catalent's global legal and compliance operations. He will be based at the company's headquarters in Somerset, New Jersey, head up the company's Legal Leadership Team, and serve on its Executive Leadership Team, reporting directly to Catalent's Executive Vice President and Chief Administrative Officer, Steven Fasman. This press release features multimedia. View the full release here: https:/

    2/13/23 8:00:00 AM ET
    $CTLT
    $PSEC
    $VATE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance

    INNOVATE Corp. Announces Appointment of Amy Wilkinson to the Board of Directors

    NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE), today announced the appointment of Amy Wilkinson to fill the remaining vacancy on the INNOVATE Board of Directors. "Amy brings a unique blend of management expertise and global business and policy experience, and we are confident she will help guide us in our mission to drive shareholder value across our Infrastructure, Life Sciences and Spectrum operating segments," said Avie Glazer, Chairman of INNOVATE. "Amy's leadership and strategy consulting experience advising Fortune 500 companies will be a valuable addition to our Board," said Wayne Barr, Jr., Chief Executive Officer of INNOVATE

    8/2/22 4:15:00 PM ET
    $VATE
    Metal Fabrications
    Industrials

    $VATE
    Financials

    Live finance-specific insights

    View All

    INNOVATE Corp. Announces Fourth Quarter and Full Year 2025 Results

    - Infrastructure: NYC and Western markets continue to demonstrate positive project momentum -- Life Sciences: R2 Secures 600‑System Commitment in China -- Spectrum: Recent network launches set to deliver benefits beginning in 2026 - NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the fourth quarter and full year ended December 31, 2025. Financial Summary (in millions, except per share amounts)Three Months Ended December 31, Year Ended December 31,  2025   2024  Increase / (Decrease)  2025   2024  Increase / (Decrease)Revenue$382.7  $236.6  61.7% $1,246.0  $1,107.1  12.5%Net loss attributab

    3/26/26 4:05:00 PM ET
    $VATE
    Metal Fabrications
    Industrials

    INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th

    NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the fourth quarter and full year 2025 on Thursday, March 26, 2026, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please

    3/16/26 4:05:00 PM ET
    $VATE
    Metal Fabrications
    Industrials

    INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend

    NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that DBM Global Inc. ("DBMG"), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $5 million, or $1.30 per share, on February 24, 2026 to DBMG's stockholders of record at the close of business on February 9, 2026. As the largest stockholder of DBMG, INNOVATE expects to receive approximately $4.6 million of the total $5 million dividend payout. INNOVATE's individual stockholders are not eligible to receive the cash dividend. About INNOVATEINNOVATE Corp. is a portfoli

    2/2/26 8:30:00 AM ET
    $VATE
    Metal Fabrications
    Industrials

    $VATE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by INNOVATE Corp.

    SC 13G/A - INNOVATE Corp. (0001006837) (Subject)

    11/13/24 9:30:32 PM ET
    $VATE
    Metal Fabrications
    Industrials

    Amendment: SEC Form SC 13D/A filed by INNOVATE Corp.

    SC 13D/A - INNOVATE Corp. (0001006837) (Subject)

    6/21/24 7:05:53 PM ET
    $VATE
    Metal Fabrications
    Industrials

    SEC Form SC 13D/A filed by INNOVATE Corp. (Amendment)

    SC 13D/A - INNOVATE Corp. (0001006837) (Subject)

    4/1/24 4:18:15 PM ET
    $VATE
    Metal Fabrications
    Industrials